3.680PLN-3.66%Mkt Cap: 15.90M $P/E: —1d ago
Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that enables t…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap15.90M $
Enterprise Value13.85M $
Revenue (TTM)7.60K $
Gross Profit-2.02M $
Net Income (TTM)-2.64M $
Revenue/Share0.0005 USD
Last Price3.680 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees32
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLGNMTC00017
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-9.02
EV/Revenue1823.13
P/S2147.30
P/B8.10
EPS (TTM)-0.62
EPS (Forward)—
52W Range
3.24511% of range7.330
52W High7.330 PLN
52W Low3.245 PLN
Profitability
Gross Margin-37909.52%
Oper. Margin-13387.50%
EBITDA Margin0.00%
Profit Margin-49671.43%
ROE-113.21%
ROA-67.92%
Growth
Revenue Growth220.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.83M $
CapEx (TTM)23.30K $
FCF Margin-22987.50%
FCF Yield-10.98%
Net Debt-188.43K $
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity0.21
Current Ratio1.77
Quick Ratio1.52
Book Value/Sh0.4660 PLN
Cash/Share0.1730 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.17.06M
Float9.40M
Insiders7.07%
Institutions11.76%
Technical
SMA 504.453 (-17.4%)
SMA 2004.684 (-21.4%)
Beta0.31
S&P 52W Chg18.16%
Avg Vol (30d)41.92K
Avg Vol (10d)27.54K
Technical Indicators
RSI (14)34.9
MACD-0.1960
MACD Signal-0.1937
MACD Hist.-0.0023
BB Upper4.422 PLN
BB Middle3.971 PLN
BB Lower3.520 PLN
BB Width22.71%
ATR (14)0.2305 PLN
Vol Ratio (20d)0.06x